Keyphrases
Pregnant Women
100%
Antiretroviral Therapy
100%
AIDS/HIV
100%
Living with
100%
Randomized Controlled Trial
100%
Virus B
100%
Hepatitis B Virus
100%
Antepartum
25%
Aspartate Aminotransferase
25%
Hepatitis B e Antigen (HBeAg)
25%
Co-infection
16%
Viral Load
16%
Alanine Aminotransferase
16%
Perinatal Transmission
16%
Aminotransferase Elevation
16%
Hepatitis B Virus Treatment
16%
Anemia
8%
Hemoglobin
8%
Viremic
8%
Treatment Group
8%
T-test
8%
Gestational Age
8%
Active Treatment
8%
Virus Transmission
8%
Multicenter Randomized Trial
8%
Perinatal Safety
8%
Antiretroviral Therapy Regimens
8%
Safety Assessment
8%
Human Immunodeficiency Virus Infection
8%
Pairwise Comparison
8%
Single Group
8%
Active Agent
8%
Week of Gestation
8%
Period-one
8%
Change from Baseline
8%
Serologic
8%
Fisher's Exact Test
8%
Antiretroviral Naïve
8%
Load Change
8%
Maternal Survival
8%
Activity Groups
8%
Aminotransferase Levels
8%
Hepatitis B Virus DNA
8%
Alanine Aminotransferase Level
8%
Hepatitis B Virus Infection
8%
International Units
8%
Infant Survival
8%
HBsAg-positive
8%
Active Antiretroviral Therapy
8%
Anti-hepatitis B Virus
8%
Anti-hepatitis B Virus Activity
8%
HBeAg Loss
8%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Hepatitis B Virus
100%
Randomized Controlled Trial
100%
Aspartate Aminotransferase
17%
Alanine Aminotransferase
17%
Hepatitis B(e) Antigen
17%
Arm
17%
Mixed Infection
11%
Anemia
5%
Safety Assessment
5%
Human Immunodeficiency Virus Infection
5%
Hepatitis B
5%
Student T Test
5%
Fisher Exact Test
5%
Virus Transmission
5%
Hepatitis B Antigen
5%
Virus DNA
5%
Infant Survival
5%
Gestational Age
5%
Treatment Group
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Randomized Controlled Trial
100%
Hepatitis B Virus
100%
Aspartate Aminotransferase
17%
Alanine Aminotransferase
17%
Hepatitis B(e) Antigen
17%
Mixed Infection
11%
Safety Assessment
5%
Human Immunodeficiency Virus Infection
5%
Virus DNA
5%
Hepatitis B
5%
Virus Transmission
5%
Anemia
5%
Hepatitis B Antigen
5%
Treatment Group
5%